Role of the dependence receptor DCC in colorectal cancer pathogenesis

Journal of Clinical Oncology

Volumn 22, Issue 16, 2004, Pages 3420-3428

  Mehlen, Patrick ^a   Fearon, Eric R ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DELETED IN COLORECTAL CANCER PROTEIN; MEMBRANE RECEPTOR; NETRIN; NETRIN 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DCC PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM; COLORECTAL CANCER; HUMAN; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPINAL CORD; TUMOR SUPPRESSOR GENE; BINDING SITE; COLORECTAL TUMOR; GENETICS; PATHOPHYSIOLOGY; REVIEW;

APOPTOSIS; BINDING SITES; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 4344716258     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.02.019     Document Type: Article

References (100)

1. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990
2. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57-70, 2000
3. Cavenee WK, Dryja TP, Phillips RA, et al: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779-784, 1983
4. Knudson AG Jr: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437-1443, 1985
5. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532, 1988
6. Vogelstein B, Fearon ER, Kern SE, et al: Allelotype of colorectal carcinomas. Science 244:207-211, 1989
7. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87:159-170, 1996
8. Fearon ER, Cho KR, Nigro JM, et al: Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49-56, 1990
9. Cho KR, Oliner JD, Simons JW, et al: The DCC gene: Structural analysis and mutations in colorectal carcinomas. Genomics 19:525-531, 1994
10. Ekstrand BC, Mansfield TA, Bigner SH, et al: DCC expression is altered by multiple mechanisms in brain tumours. Oncogene 11:2393-2402, 1995
11. Reale MA, Hu G, Zafar AI, et al: Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res 54:4493-4501, 1994
12. Meyerhardt JA, Look AT, Bigner SH, et al: Identification and characterization of neogenin, a DCC-related gene. Oncogene 14:1129-1136, 1997
13. Chan SS, Zheng H, Su MW, et al: UNC-40, a C. elegans homolog of DCC (Deleted in Colorectal Cancer), is required in motile cells responding to UNC-6 netrin cues. Cell 87:187-195, 1996
14. Hedgecock EM, Culotti JG, Hall DH: The unc-5, unc-6, and unc-40 genes guide circumferential migrations of pioneer axons and mesodermal cells on the epidermis in C. elegans. Neuron 4:61-85, 1990
15. Kolodziej PA, Timpe LC, Mitchell KJ, et al: Frazzled encodes a Drosophila member of the DCC immunoglobulin subfamily and is required for CNS and motor axon guidance. Cell 87:197-204, 1996
16. Pierceall WE, Reale MA. Candia AF, et al: Expression of a homologue of the deleted in colorectal cancer (DCC) gene in the nervous system of developing Xenopus embryos. Dev Biol 166:654-665, 1994
17. Keino-Masu K, Masu M, Hinck L, et al: Deleted in Colorectal Cancer (DCC) encodes a netrin receptor. Cell 87:175-185, 1996
18. Watanabe T, Wu TT, Catalano PJ, et al: Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344:1196-1206, 2001
19. Thiagalingam S, Lengauer C, Leach FS, et al: Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13:343-346, 1996
20. Itoh F, Hinoda Y, Ohe M, et al: Decreased expression of DCC mRNA in human colorectal cancers. Int J Cancer 53:260-263, 1993
21. Goi T, Yamaguchi A, Nakagawara G, et al: Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers. Br J Cancer 77:466-471, 1998
22. Schmitt CA, Thaler KR, Wittig BM, et al: Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation. Br J Cancer 77:588-594, 1998
23. Tarafa G, Villanueva A, Farre L, et al: DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination. Oncogene 19:546-555, 2000
24. Gotley DC, Reeder JA, Fawcett J, et al: The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene 13:787-795, 1996
25. Uchino S, Tsuda H, Noguchi M, et al: Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 52:3099-3102, 1992
26. Fang DC, Jass JR, Wang DX: Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J Clin Pathol 51:593-596, 1998
27. Yoshida Y, Itoh F, Endo T, et al: Decreased DCC mRNA expression in human gastric cancers is clinicopathologically significant. Int J Cancer 79:634-639, 1998
28. Brewster SF, Gingell JC, Browne S, et al: Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer 70:697-700, 1994
29. Latil A, Baron JC, Cussenot O, et al: Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome arm 18q. Genes Chromosomes Cancer 11:119-125, 1994
30. Latil A, Chene L, Cochant-Priollet B, et al: Quantification of expression of netrins, slits and their receptors in human prostate tumors. Int J Cancer 103:306-315, 2003
31. Imamura T, Arima T, Kato H, et al: Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas. Int J Cancer 51:47-52, 1992
32. Gima T, Kato H, Honda T, et al: DCC gene alteration in human endometrial carcinomas. Int J Cancer 57:480-485, 1994
33. Enomoto T, Fujita M, Cheng C, et al: Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Br J Cancer 71:462-467, 1995
34. Ronnett BM, Burks RT, Cho KR, et al: DCC genetic alterations and expression in endometrial carcinoma. Mod Pathol 10:38-46, 1997
35. Saegusa M, Hashimura M, Hara A, et al: Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic differentiation and lymph node metastasis in endometrial carcinoma. Cancer 85:453-464, 1999
36. Saegusa M, Machida D, Okayasu I: Loss of DCC gene expression during ovarian tumorigenesis: Relation to tumour differentiation and progression. Br J Cancer 82:571-578, 2000
37. Huang Y, Boynton RF, Blount PL, et al: Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 52:6525-6530, 1992
38. Dolan K, Garde J, Gosney J, et al: Allelotype analysis of oesophageal adenocarcinoma: Loss of heterozygosity occurs at multiple sites. Br J Cancer 78:950-957, 1998
39. Jenkins GJ, Doak SH, Parry JM, et al: Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma. Br J Surg 89:824-837, 2002
40. Devilee P, van Vliet M, Kuipers-Dijkshoorn N, et al: Somatic genetic changes on chromosome 18 in breast carcinomas: Is the DCC gene involved? Oncogene 6:311-315, 1991
41. Thompson AM, Morris RG, Wallace M, et al: Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 68:64-68, 1993
42. Ho KY, Kalle WH, Lo TH, et al: Reduced expression of APC and DCC gene protein in breast cancer. Histopathology 35:249-256, 1999
43. Murty W, Li RG, Houldsworth J, et al: Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors. Oncogene 9:3227-3231, 1994
44. Strohmeyer D, Langenhof S, Ackermann R, et al: Analysis of the DCC tumor suppressor gene in testicular germ cell tumors: Mutations and loss of expression. J Urol 157:1973-1976, 1997
45. Scheck AC, Coons SW: Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res 53:5605-5609, 1993
46. Reyes-Mugica M, Rieger-Christ K, Ohgaki H, et al: Loss of DCC expression and glioma progression. Cancer Res 57:382-386, 1997
47. Hara A, Saegusa M, Mikami T, et al: Loss of DCC expression in astrocytomas: Relation to p53 abnormalities, cell kinetics, and survival. J Clin Pathol 54:860-865, 2001
48. Kong XT, Choi SH, Inoue A, et al: Alterations of the tumour suppressor gene DCC in neuroblastoma. Eur J Cancer 33:1962-1965, 1997
49. Reyes-Mugica M, Lin P, Yokota J, et al: Status of deleted in colorectal cancer gene expression correlates with neuroblastoma metastasis. Lab Invest 78:669-675, 1998
50. Porfiri E, Seeker-Walker LM, Hoffbrand AV, et al: DCC tumor suppressor gene is inactivated in hematologic malignancies showing monosomy 18. Blood 81:2696-2701, 1993
51. Miyake K, Inokuchi K, Dan K, et al: Alterations in the deleted in colorectal carcinoma gene in human primary leukemia. Blood 82:927-930, 1993
52. Miyake K, Inokuchi K, Nomura T: Expression of the DCC gene in human hematological malignancies. Leuk Lymphoma 16:13-18, 1994
53. Inokuchi K, Yamaguchi H, Hanawa H, et al: Loss of DCC gene expression is of prognostic importance in acute myelogenous leukemia. Clin Cancer Res 8:1882-1888, 2002
54. Jen J, Kim H, Piantadosi S, et al: Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331:213-221, 1994
55. Lanza G, Matteuzzi M, Gafa R, et al: Chromosome 18q allelic loss and prognosis in stage II and III colon cancer. Int J Cancer 79:390-395, 1993
56. Martinez-Lopez E, Abad A, Font A, et al: Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 114:1180-1187, 1998
57. Ogunbiyi OA, Goodfellow PJ, Herfarth K, et al: Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 16:427-433, 1998
58. Barratt PL, Seymour MT, Stenning SP, et al: DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: A molecular study. Lancet 360:1381-1391, 2002
59. Shibata D, Reale MA, Lavin P, et al: The DCC protein and prognosis in colorectal cancer. N Engl J Med 335:1727-1732, 1996
60. Sun XF, Rutten S, Zhang H, et al: Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma. J Clin Oncol 17:1745-1750, 1999
61. Saito M, Yamaguchi A, Goi T, et al: Expression of DCC protein in colorectal tumors and its relationship to tumor progression and metastasis. Oncology 56:134-141, 1999
62. Saw RP, Koorey D, Painter D, et al: p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer. Br J Surg 89:1409-1415, 2002
63. Tanaka K, Oshimura M, Kikuchi R, et al: Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature 349:340-342, 1991
64. Klingelhutz AJ, Smith PP, Garrett LR, et al: Alteration of the DCC tumor-suppressor gene in tumorigenic HPV-18 immortalized human keratinocytes transformed by nitrosomethylurea. Oncogene 8:95-99, 1993
65. Velcich A, Corner G, Palumbo L, et al: Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene. Oncogene 18:2599-2606, 1999
66. Kato H, Zhou Y, Asanoma K, et al: Suppressed tumorigenicity of human endometrial cancer cells by the restored expression of the DCC gene. Br J Cancer 82:459-466, 2000
67. Hilgers W, Song JJ, Haye M, et al: Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers. Genes Chromosomes Cancer 27:353-357, 2000
68. Marra G, Boland CR: Hereditary nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87:1114-1125, 1995
69. Attisano L, Wrana JL: Signal transduction by the TGF-beta superfamily. Science 296:1646-1647, 2002
70. Eppert K, Scherer SW, Ozcelik H, et al: MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543-552, 1996
71. Riggins GJ, Thiagalingam S, Rozenblum E, et al: Mad-related genes in the human. Nat Genet 13:347-349, 1996
72. Takagi Y, Koumura H, Futamura M, et al: Somatic alterations of the SMAD-2 gene in human colorectal cancers. Br J Cancer 78:1152-1155, 1998
73. Takenoshita S, Tani M, Mogi A, et al: Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers. Carcinogenesis 19:803-807, 1998
74. Ohtaki N, Yamaguchi A, Goi T, et al: Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis. Int J Oncol 18:265-270, 2001
75. Howe JR, Roth S, Ringold JC, et al: Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280:1086-1088, 1998
76. Hahn SA, Schutte M, Hoque AT, et al: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353, 1996
77. Takaku K, Oshima M, Miyoshi H, et al: Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92:645-656, 1998
78. Koyama M, Ito M, Nagai H, et al: Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: Identification of seven novel somatic mutations in tumors from Japanese patients. Mutat Res 406:71-77, 1999
79. Montgomery E, Goggins M, Zhou S, et al: Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects. Am J Pathol 158:537-542, 2001
80. Korchynskyi O, Landstrom M, Stoika R, et al: Expression of Smad proteins in human colorectal cancer. Int J Cancer 82:197-202, 1999
81. Salovaara R, Roth S, Loukola A, et al: Frequent loss of SMAD4/DPC4 protein in colorectal cancers. Gut 51:56-59, 2002
82. Fazeli A, Dickinson SL, Hermiston ML, et al: Phenotype of mice lacking functional Deleted in colorectal cancer (Dec) gene. Nature 386:796-804, 1997
83. Macleod KF, Jacks T: Insights into cancer from transgenic mouse models. J Pathol 187:43-60, 1999
84. Shoemaker AR, Luongo C, Moser AR, et al: Somatic mutational mechanisms involved in intestinal tumor formation in Min mice. Cancer Res 57:1999-2006, 1997
85. Smits R, Kartheuser A, Jagmohan-Changur S, et al: Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis 18:321-327, 1997
86. Kim SH, Roth KA, Moser AR, et al: Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia. J Cell Biol 123:877-893, 1993
87. Fazeli A, Steen RG, Dickinson SL, et al: Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. Proc Natl Acad Sci U S A 94:10199-10204, 1997
88. Janssen KP, el-Marjou F, Pinto D, et al: Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology 123:492-504, 2002
89. Edelman GM, Crossin KL: Cell adhesion molecules: Implications for a molecular histology. Annu Rev Biochem 60:155-190, 1991
90. Rutishauser U: Defining a role and mechanism for IgCAM function in vertebrate axon guidance. J Cell Biol 149:757-760, 2000
91. Chuong CM, Jiang TX, Yin E, et al: CDCC (chicken homologue to a gene deleted in colorectal carcinoma) is an epithelial adhesion molecule expressed in the basal cells and involved in epithelial-mesenchymal interaction. Dev Biol 164:383-397, 1994
92. Serafini T, Kennedy TE, Galko MJ, et al: The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 78:409-424, 1994
93. Serafini T, Colamarino SA, Leonardo ED, et al: Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell 87:1001-1014, 1996
94. Bennett KL, Bradshaw J, Youngman T, et al: Deleted in colorectal carcinoma (DCC) binds heparin via its fifth fibronectin type III domain. J Biol Chem 272:26940-26946, 1997
95. Ackerman SL, Kozak LP, Przyborski SA, et al: The mouse rostral cerebellar malformation gene encodes an UNC-5-like protein. Nature 386:838-842, 1997
96. Leonardo ED, Hinck L, Masu M, et al: Vertebrate homologues of C. elegans UNC-5 are candidate netrin receptors. Nature 386:833-838, 1997
97. Tessier-Lavigne M, Goodman CS: The molecular biology of axon guidance. Science 274:1123-1133, 1996
98. Manitt C, Kennedy TE: Where the rubber meets the road: Netrin expression and function in developing and adult nervous systems. Prog Brain Res 137:425-442, 2002
99. Meyerhardt JA, Caca K, Eckstrand BC, et al: Netrin-1: interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas. Cell Growth Differ 10:35-42, 1999
100. Wang H, Copeland NG, Gilbert DJ, et al: Netrin-3, a mouse homolog of human NTN2L, is highly expressed in sensory ganglia and shows differential binding to netrin receptors. J Neurosci 19:4938-4947, 1999